Indian markets experienced a downturn on Thursday, with profit-taking and a risk-off sentiment leading to a decline. Key stocks like Federa...

Zydus Lifesciences has introduced Anyra, its first indigenously developed biosimilar for the treatment of visual impairment in India. This ...

Indian markets saw a rebound on Friday, driven by positive global sentiment. Key companies like Wipro, Dr Reddy's, Tata Steel, and SAIL are...

Alkem Laboratories has launched Pertuza, a biosimilar of pertuzumab, in India for treating HER2-positive breast cancer. This indigenously d...

Nivruti Rai is upbeat on what India did for phone assembly and said that since India is already putting together cars, the country should f...

The scheme intends to promote indigenous manufacture of complex generics, biosimilars and high value-add medicines, to boost domestic drug ...

Cipla Executive Vice-Chairperson Samina Vaziralli said with the government returning for a second consecutive five-year term armed with a s...

Biosimilars are approved versions of biopharmaceuticals — complex medicines manufactured using live organisms, as against conventional drug...

While the market opportunities to sell brands appear optimistic, that road is less treaded by Indian companies and obvious challenges can l...

Intas is the only domestic firm with two biosimilars filed for registration in the US and it looks to deliver affordable and innovative pha...

It is not just Big Pharma that has to prepare for life after the 'patent cliff'' patent expiries on a slew of blockbuster drugs.